SCHEMBL23765173

SCHEMBL23765173

CCCc1cc(OC(=O)c2ccc3ccccc3c2)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 18/20 0.58
CNR1 P21554 8/20 0.58
TRPM8 Q7Z2W7 2/20 0.58
GPR55 Q9Y2T6 2/20 0.58
TRPA1 O75762 1/20 0.58
HTR1A P08908 1/20 0.58
TRPV1 Q8NER1 1/20 0.58
TRPV3 Q8NET8 1/20 0.58
TRPV6 Q9H1D0 1/20 0.58
TRPV4 Q9HBA0 1/20 0.58
TRPV5 Q9NQA5 1/20 0.58
TRPV2 Q9Y5S1 1/20 0.58
ABHD12 Q8N2K0 3/20 0.51
ABHD6 Q9BV23 3/20 0.51
FAAH O00519 2/20 0.51
NR1I2 O75469 1/20 0.51
LDHA P00338 1/20 0.51
GLRA1 P23415 1/20 0.51
GPR183 P32249 1/20 0.51
DRD3 P35462 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23765328 0.95 CNR2 (0.59) CNR2CNR1TRPM8GPR55TRPA1
SCHEMBL25268322 0.94 CNR2 (0.61) CNR2CNR1TRPM8GPR55ABHD12
SCHEMBL22946285 0.94 CNR2 (0.61) CNR2CNR1TRPM8GPR55ABHD12
SCHEMBL23765260 0.94 CNR2 (0.61) CNR2CNR1TRPM8GPR55ABHD12
SCHEMBL25258533 0.85 CNR2 (0.66) CNR2CNR1TRPM8GPR55ABHD12
SCHEMBL25258530 0.85 CNR2 (0.66) CNR2CNR1TRPM8GPR55ABHD12
SCHEMBL23765210 0.85 CNR1 (0.64) CNR2CNR1
SCHEMBL19472305 0.84 CNR2 (0.70) CNR2CNR1TRPM8GPR55TRPA1
SCHEMBL19472298 0.82 CNR2 (0.67) CNR2CNR1TRPM8GPR55TRPA1
SCHEMBL25269138 0.82 CNR2 (0.40) CNR2CNR1TRPM8GPR55TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230375561-A1 METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES KADDURAH DAOUK RIMA F (US) 2023-11-23 US disclosed
US-20230375561-A1 METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES KADDURAH DAOUK RIMA F (US) 2023-11-23 US disclosed
WO-2021163023-A1 STABLE FORMULATIONS OF DRONABINOL TRYAGx Labs Inc. (US) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230375561-A1 METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES SLC25A20, CPT2, NDUFAB1 CNR2 91/4885CNR1 106/4885TRPM8 2982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.